Home » Topics » Disease categories and therapies » Infection

Infection
RSS

NHLBI awards SBIR grant to Pentose for viral inactivation technology

Nov. 5, 1999

Pliva patents novel antibiotics from the macrolide class

Nov. 4, 1999

Ribavirin derivative exerts potent synergistic antiviral activity

Nov. 4, 1999

Avanir reports positive developments in docosanol approval process

Nov. 3, 1999

Coumarin inhibitors of DNA gyrase in development at HMR

Nov. 2, 1999

Risk of sitafloxacin-resistant mutants is expected to be low

Nov. 2, 1999

Inhibitex receives clearance to begin clinical trials of S. aureus prophylactic

Nov. 2, 1999

New polyaromatic compounds for herpesvirus infections designed at P&U

Nov. 2, 1999

Tamiflu approved in time for U.S. flu season

Oct. 28, 1999

Glaxo Wellcome withdraws antibiotic due to safety concerns

Oct. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...